The role of Rac in tumor susceptibility and disease progression: from biochemistry to the clinic
- 31 July 2018
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 46 (4) , 1003-1012
Abstract
The family of Rho GTPases are involved in the dynamic control of cytoskeleton reorganization and other fundamental cellular functions, including growth, motility, and survival. Rac1, one of the best characterized Rho GTPases, is an established effector of receptors and an important node in signaling networks crucial for tumorigenesis and metastasis. Rac1 hyperactivation is common in human cancer and could be the consequence of overexpression, abnormal upstream inputs, deregulated degradation, and/or anomalous intracellular localization. More recently, cancer-associated gain-of-function mutations in Rac1 have been identified which contribute to tumor phenotypes and confer resistance to targeted therapies. Deregulated expression/activity of Rac guanine nucleotide exchange factors responsible for Rac activation has been largely associated with a metastatic phenotype and drug resistance. Translating our extensive knowledge in Rac pathway biochemistry into a clinical setting still remains a major challenge; nonetheless, remarkable opportunities for cancer therapeutics arise from promising lead compounds targeting Rac and its effectors.Keywords
This publication has 107 references indexed in Scilit:
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanomaNature Genetics, 2012
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Melanoma genome sequencing reveals frequent PREX2 mutationsNature, 2012
- Characterization of EHop-016, Novel Small Molecule Inhibitor of Rac GTPaseJournal of Biological Chemistry, 2012
- Rho protein crosstalk: another social network?Trends in Cell Biology, 2011
- P-Rex1 is required for efficient melanoblast migration and melanoma metastasisNature Communications, 2011
- Identification of the Rac-GEF P-Rex1 as an Essential Mediator of ErbB Signaling in Breast CancerMolecular Cell, 2010
- Rac1 Recruits the Adapter Protein CMS/CD2AP to Cell-Cell ContactsJournal of Biological Chemistry, 2010
- Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2aScience, 2009
- Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasisOncogene, 2009